DRUG · Unmapped registry intervention
SHR-A1811
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
NCT04818333
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Non-small Cell Lung Cancerunresolved
Interventions
SHR-A1811DRUG
Sponsors & collaborators
Jiangsu HengRui Medicine Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04818333 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.